TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2405747

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol (25 mg per actuation, qid, for 4 weeks)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aerosol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Triamcinolone acetonide aerosol and Placebo
Number of subjects: 180
Study: 7408227

Group type: EXPERIMENTAL
Intervention: Bipolar diathermy for haemostasis in tonsillectomy
Number of subjects: 0
Study: 31860405

Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reduced-intensity conditioning (RIC)
Number of subjects: 0
Study: 31305092

Group type: EXPERIMENTAL
Intervention: Dishonest behavior
Number of subjects: 2588
Study: 29210815

Group type: EXPERIMENTAL
Intervention: Advice from home care nurses on fiber intake, liquid intake, mobilization, laxative administration, and physician referral
Number of subjects: 59
Study: 26373705

Group type: EXPERIMENTAL
Intervention: Laxative therapy (lactulose and enemas)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (absence of defecation tolerated up to 5 days)
Number of subjects: 88
Study: 23642378

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Supportive therapy (ST)
Number of subjects: 241
Study: 21249462

Group type: EXPERIMENTAL
Intervention: Financial incentive plan (Deposit contracts, matched 1:1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weight-monitoring program (control condition)
Number of subjects: 0
Study: 19380447

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 2122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2122
Study: 17578484

Group type: COMPARATOR
Intervention: 300 microg capsaicin
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1000 microg capsaicin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15223721

Group type: EXPERIMENTAL
Intervention: Newer drugs (ACE inhibitors, calcium antagonists)
Number of subjects: 2280

Group type: COMPARATOR
Intervention: Conventional therapy (diuretics, beta-blockers)
Number of subjects: 2280
Study: 11816637

Group type: EXPERIMENTAL
Intervention: Combipolar sensing configuration
Number of subjects: 26

Group type: COMPARATOR
Intervention: Unipolar sensing
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combipolar sensing
Number of subjects: 26
Study: 9161624

Group type: EXPERIMENTAL
Intervention: Granisetron 10 micrograms/kg i.v. over 5 minutes
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Granisetron 10 micrograms/kg i.v. over 30 seconds
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ondansetron 32 mg i.v. over 15 minutes
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8125423

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3508564

Group type: EXPERIMENTAL
Intervention: Three production lots of macrocrystalline nitrofurantoin capsules (Macrodantin)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Capsules from one production lot administered on three occasions
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 21
Study: 2744361

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the esophagus at 37 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the esophagus at 0.5 and 1.0 Hz
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Electrical stimulation at 37 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Irregular stimulation and stimulation during mental distraction
Number of subjects: 11
Study: 31520099

Group type: EXPERIMENTAL
Intervention: Physical exertion (PE) - combined isometric modified Biering‐Sörensen and static abdominal curl
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cognitive exertion (CE) - modified incongruent Stroop colour‐word task
Number of subjects: 20

Group type: COMPARATOR
Intervention: Seated rest without exertion (NE)
Number of subjects: 20
Study: 26892006

Group type: EXPERIMENTAL
Intervention: Pregabalin plus paroxetine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pregabalin plus amitriptyline
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pregabalin plus venlafaxine
Number of subjects: 75
Study: 25992866

Group type: EXPERIMENTAL
Intervention: Postoperative cold patch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wash group (ice-cold balanced salt solution)
Number of subjects: 40
Study: 22616762

Group type: EXPERIMENTAL
Intervention: SRT2104 (doses ranging from 0.03 to 3.0 g)
Number of subjects: 0
Study: 22303708

Group type: COMPARATOR
Intervention: Probucol Tablet (PT) 0.5 g, twice daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Lumbrukinase Capsule (LC) 600 thousand U, thrice daily + Probucol Tablet (PT)
Number of subjects: 150
Study: 19335806

Group type: EXPERIMENTAL
Intervention: Training and knowledge assessment of lifeguards regarding anaphylaxis management
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Possession of emergency kits for anaphylaxis management
Number of subjects: 50
Study: 16707027

Group type: EXPERIMENTAL
Intervention: Routine completion and feedback of outcome measures (FOCUS intervention)
Number of subjects: 160
Study: 14982689

Group type: EXPERIMENTAL
Intervention: 12 mg nicotine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 8 mg nicotine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Repeated dosing with The Straw
Number of subjects: 24
Study: 11502768

Group type: EXPERIMENTAL
Intervention: 131I plus pretreatment with methimazole (30 mg/d)
Number of subjects: 61

Group type: COMPARATOR
Intervention: 131I alone
Number of subjects: 61
Study: 9248982

Group type: EXPERIMENTAL
Intervention: Postoperative changes in serum concentrations of IL-2 after major operations
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative changes in serum concentrations of IL-2 after intermediate operations
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative changes in serum concentrations of IL-2 after minor operations
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative antiprostaglandins and H2-blockers
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy age and sex matched controls
Number of subjects: 43
Study: 8215594

Group type: EXPERIMENTAL
Intervention: Pleasant odor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unpleasant odor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No odor
Number of subjects: 0
Study: 3544982

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg plus Hydroxyzine 50 mg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 50 mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 30428134

Group type: EXPERIMENTAL
Intervention: Taoist qigong training program for one month
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study: 28399810

Group type: COMPARATOR
Intervention: Implementation of an off-line database that integrates laboratory results and generates eGFR graphs over time.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of eGFR graph surveillance intervention.
Number of subjects: 0
Study: 24838062

Group type: EXPERIMENTAL
Intervention: Cryotherapy and BSS-BSSG mixture (20 mg sterol and 0.2 mg sterolin)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Cryotherapy only
Number of subjects: 123
Study: 23439415

Group type: COMPARATOR
Intervention: Uninterrupted sitting
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Light-intensity activity breaks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Moderate-intensity activity breaks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Light-intensity and moderate-intensity breaks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Moderate-intensity breaks
Number of subjects: 19
Study: 21086166

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg bid for 1 week
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no PPIs)
Number of subjects: 70
Study: 18300257

Group type: EXPERIMENTAL
Intervention: PLD plus bortezomib
Number of subjects: 646

Group type: COMPARATOR
Intervention: Bortezomib alone
Number of subjects: 646
Study: 16937744

Group type: EXPERIMENTAL
Intervention: 3-3 group, 1 drop 3 times daily for 2 years
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2-3 group, 1 drop twice daily in year 1 and 1 drop 3 times daily in year 2
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 1-3 group, 1 drop once daily in year 1 and 1 drop 3 times daily in year 2
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group, no treatment
Number of subjects: 64
Study: 14604245

Group type: EXPERIMENTAL
Intervention: CO2 field flooding
Number of subjects: 18

Group type: COMPARATOR
Intervention: Mechanical de-airing
Number of subjects: 18
Study: 10609721

Group type: EXPERIMENTAL
Intervention: Ultrasound at first visit
Number of subjects: 648

Group type: COMPARATOR
Intervention: Control group (no ultrasound assessment)
Number of subjects: 648
Study: 7492863

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5-25 mg/day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 2020772

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carbogen breathing
Number of subjects: 15
Study: 6803944

Group type: EXPERIMENTAL
Intervention: Azathioprine (2-2.5 mg/kg body weight over six months)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 28407148

Group type: EXPERIMENTAL
Intervention: DDD-CLS pacing (60-130/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: DDD pacing (60/min)
Number of subjects: 30
Study: 26692347

Group type: EXPERIMENTAL
Intervention: MCCB
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: MCCB processing speed and attention
Number of subjects: 131

Group type: COMPARATOR
Intervention: Participants in 'low complexity' work category
Number of subjects: 131

Group type: COMPARATOR
Intervention: Participants working sheltered jobs
Number of subjects: 131
Study: 25069770

Group type: EXPERIMENTAL
Intervention: Milbemax® (milbemycin oxime/praziquantel) at a minimum target dose of 0.5 mg/kg bodyweight and 5 mg/kg bodyweight respectively, administered once every 4 weeks.
Number of subjects: 249

Group type: COMPARATOR
Intervention: Untreated group (T2) receiving specific parasiticide treatments when necessary.
Number of subjects: 249
Study: 22705017

Group type: EXPERIMENTAL
Intervention: Non-prescribed Chinese herbal medicine (CHM)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control group (no CKD)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Occasional use of non-prescribed CHM
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Illiteracy
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Regular exercise
Number of subjects: 424
Study: 20634975

Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 18382796

Group type: EXPERIMENTAL
Intervention: Fentanyl 25 micrograms with midazolam 1 mg IV
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 microgram/kg with midazolam 1 mg IV
Number of subjects: 100
Study: 15755572

Group type: EXPERIMENTAL
Intervention: HIV plasmid vaccine (combination of two HIV DNA plasmid constructs)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: HIV plasmid vaccine
Number of subjects: 13
Study: 12093983

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream
Number of subjects: 713

Group type: COMPARATOR
Intervention: Conventional treatment (emollients and topical corticosteroids)
Number of subjects: 713
Study: 9585803

Group type: EXPERIMENTAL
Intervention: Oral artemisinin (500 mg daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rectal artemisinin (500 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rectal artemisinin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral artemisinin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral treatment
Number of subjects: 30
Study: 8583211

Group type: COMPARATOR
Intervention: HAM/TSP
Number of subjects: 149

Group type: COMPARATOR
Intervention: PPMS
Number of subjects: 149

Group type: COMPARATOR
Intervention: RRMS
Number of subjects: 149
Study: 2489552

Group type: EXPERIMENTAL
Intervention: 10% Tetracycline (TC) strips
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo strips
Number of subjects: 46
Study: 69828

Group type: EXPERIMENTAL
Intervention: Levamisole (150 mg/day, 3 days/week)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 37
Study: 31618286

Group type: EXPERIMENTAL
Intervention: Thoracic drainage by the same intercostal space of thoracotomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional chest drainage approach
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 29790612

Group type: EXPERIMENTAL
Intervention: 0.5 MHz, invasive, bipolar RF treatment with longer conduction time and lower power (LC/LP)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 0.5 MHz, invasive, bipolar RF treatment with shorter conduction time and higher power (SC/HP)
Number of subjects: 2
Study: 29023508

Group type: EXPERIMENTAL
Intervention: Atazanavir (ATV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (non-ATV containing regimens)
Number of subjects: 90
Study: 26035431

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 6502

Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 6502

Group type: EXPERIMENTAL
Intervention: Leptin
Number of subjects: 6502
Study: 23678153

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg + MTX
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg + MTX
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: golimumab + MTX
Number of subjects: 444

Group type: COMPARATOR
Intervention: delayed golimumab treatment (Group 1)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg + placebo
Number of subjects: 444
Study: 21749629

Group type: EXPERIMENTAL
Intervention: Midwife-led unit
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Normal unit
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Special unit
Number of subjects: 1111
Study: 19818690

Group type: EXPERIMENTAL
Intervention: 1 g ascorbic acid per day
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: 3 g ascorbic acid per day
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 18039724

Group type: EXPERIMENTAL
Intervention: Computerized interactive decision aid
Number of subjects: 149
Study: 15969264

Group type: EXPERIMENTAL
Intervention: 2 meals replacement a day plus nutritional and physical orientation for 3 months followed by 1 meal replacement for 3 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: 1 meal replacement for 3 months followed by 1 meal replacement for 3 months (control group)
Number of subjects: 78
Study: 11336869

Group type: EXPERIMENTAL
Intervention: Automated telephone diary
Number of subjects: 105

Group type: COMPARATOR
Intervention: Written diary
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both diary modes
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Higher risk teens
Number of subjects: 105
Study: 9145445

Group type: EXPERIMENTAL
Intervention: Lactulose (2 x 10 g/d)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lactitol (2 x 10 g/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7787594

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 2122422

Group type: EXPERIMENTAL
Intervention: Enteral feedings (Ensure)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of aminophylline
Number of subjects: 6

Group type: COMPARATOR
Intervention: Phase 1 (Theo-24 6 mg/kg with 100 ml of water)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Phase 2 (Enteral feedings with Theo-24)
Number of subjects: 6
Study: 690225

Group type: EXPERIMENTAL
Intervention: Systems Releasing Action Therapy (SRAT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 31418966

Group type: EXPERIMENTAL
Intervention: 8-week home-based isometric handgrip training at 30% of maximal voluntary isometric contraction
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 29718188

Group type: EXPERIMENTAL
Intervention: Graphic warning labels (GWLs) with high emotional reaction (ER) images
Number of subjects: 73

Group type: COMPARATOR
Intervention: Graphic warning labels (GWLs) with low emotional reaction (ER) images
Number of subjects: 73
Study: 29306232

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 100 μg per day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Montelukast 4/5 mg per day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mometasone furoate + Montelukast
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study: 24823842

Group type: EXPERIMENTAL
Intervention: Tobacco Tactics intervention (nurse counseling, brochure, DVD, manual, pharmaceuticals, 1‐800‐QUIT‐NOW card, post‐discharge telephone calls)
Number of subjects: 1070

Group type: COMPARATOR
Intervention: Control site (Indianapolis)
Number of subjects: 1070
Study: 22473435

Group type: EXPERIMENTAL
Intervention: Video intervention (n = 443)
Number of subjects: 952

Group type: COMPARATOR
Intervention: Usual Bureau of Motor Vehicles license practices (control; n = 509)
Number of subjects: 952
Study: 20558967

Group type: EXPERIMENTAL
Intervention: Strength training conducted twice a week for 12 weeks.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Health education classes (control group).
Number of subjects: 119
Study: 18182669

Group type: EXPERIMENTAL
Intervention: Reduced induction therapy (no anthracyclines) for SR patients
Number of subjects: 1744

Group type: COMPARATOR
Intervention: Vincristine and dexamethasone pulses during maintenance for IR patients
Number of subjects: 1744

Group type: EXPERIMENTAL
Intervention: Conventional BFM schedule intensified with three chemotherapy blocks followed by a double reinduction phase for HR patients
Number of subjects: 1744

Group type: EXPERIMENTAL
Intervention: Favorable DNA index in IR patients
Number of subjects: 1744

Group type: EXPERIMENTAL
Intervention: Favorable DNA index in HR patients
Number of subjects: 1744
Study: 16181380

Group type: COMPARATOR
Intervention: Detection of methylated DNA in HLTF
Number of subjects: 49

Group type: COMPARATOR
Intervention: Detection of methylated DNA in hMLH1
Number of subjects: 49

Group type: COMPARATOR
Intervention: Detection of methylated DNA in APC
Number of subjects: 49

Group type: COMPARATOR
Intervention: Overall detection of methylated DNA in at least one marker
Number of subjects: 49

Group type: COMPARATOR
Intervention: Detection of methylation in two markers
Number of subjects: 49

Group type: COMPARATOR
Intervention: Detection of methylation in at least one marker
Number of subjects: 49
Study: 14566763

Group type: EXPERIMENTAL
Intervention: Educational intervention by a renal dietitian
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study: 10384893

Group type: EXPERIMENTAL
Intervention: Noise exposure with stimulus combination L1 = 65 dB, L1‐L2 = 25 dB, f2/f1 = 1.18
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Noise exposure with other stimulus combinations (L1 = 65 dB, L1‐L2 = 25 dB, f2/f1 = 1.22 and 1.20)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not exposed to noise)
Number of subjects: 27
Study: 7479175

Group type: EXPERIMENTAL
Intervention: Lead-SQ Array
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lead-alone
Number of subjects: 20
Study: 2319048

Group type: EXPERIMENTAL
Intervention: Panic Control Treatment (PCT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 57
Study: 6766653

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (40 mg four times daily for 3 months)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (40 mg four times daily for 3 months)
Number of subjects: 19
Study: 31918400

Group type: EXPERIMENTAL
Intervention: Social justice framing
Number of subjects: 3758

Group type: EXPERIMENTAL
Intervention: Impact on children framing
Number of subjects: 3758
Study: 30822774

Group type: EXPERIMENTAL
Intervention: F17464, 20 mg twice daily
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 28918213

Group type: EXPERIMENTAL
Intervention: Aldrich score
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Hasche score
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: van Hellemond score
Number of subjects: 98

Group type: COMPARATOR
Intervention: CMR
Number of subjects: 98
Study: 25540069

Group type: EXPERIMENTAL
Intervention: Intraoperative morphine guided by ANI
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (intraoperative morphine guided by anaesthetist with ANI concealed)
Number of subjects: 120
Study: 23993224

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous ketorolac preoperatively
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 85
Study: 21813441

Group type: EXPERIMENTAL
Intervention: Active training treatment (strength training)
Number of subjects: 47
Study: 19127194

Group type: EXPERIMENTAL
Intervention: Lifestyle change group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 100
Study: 17909351

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy
Number of subjects: 66
Study: 15099455

Group type: EXPERIMENTAL
Intervention: Home-administered influenza vaccination
Number of subjects: 1865
Study: 11309872

Group type: EXPERIMENTAL
Intervention: Inhalation sedation (IHS)
Number of subjects: 88

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 88